Table 2 Summary of the quality assessment of included studies using an adapted version of the Newcastle-Ottawa scale for assessing the quality of nonrandomised studies
From: Weight change during chemotherapy in breast cancer patients: a meta-analysis
First author, year of publication | Representativeness of sample (2 points) | Loss to follow-up of participants (1 point) | Information about exposure (1 point) | Measurement of outcome (2 points) | Total score |
|---|---|---|---|---|---|
Foltz, 1985 [32] | 2 | 1 | 1 | 1 | 5/6 |
Heasman, 1985 [33] | 2 | 1 | 1 | 1 | 5/6 |
Huntington, 1985 [34] | 1 | 0 | 1 | 1 | 3/6 |
Goodwin, 1988 [35] | 2 | 1 | 1 | 1 | 5/6 |
Demark-Wahnefried, 1997 [13] | 1 | 1 | 0 | 1 | 3/6 |
Aslani, 1999 [36] | 1 | 1 | 1 | 1 | 4/6 |
Goodwin, 1999 [37] | 1 | 1 | 0 | 2 | 4/6 |
Kutynec, 1999 [38] | 2 | 1 | 1 | 1 | 5/6 |
Demark-Wahnefried, 2001 [12] | 2 | 1 | 0 | 2 | 5/6 |
McInnes, 2001 [1] | 1 | 1 | 0 | 1 | 3/6 |
Del Rio, 2002 [39] | 1 | 1 | 1 | 0 | 3/6 |
Lankester, 2002 [40] | 1 | 1 | 0 | 1 | 3/6 |
Freedman, 2004 [7] | 1 | 1 | 0 | 2 | 4/6 |
Harvie, 2004 [18] | 1 | 1 | 0 | 2 | 4/6 |
Ingram, 2004 [6] | 2 | 1 | 1 | 2 | 6/6 |
Kumar, 2004 [41] | 2 | 1 | 0 | 1 | 4/6 |
Campbell, 2007 [19] | 1 | 1 | 0 | 2 | 4/6 |
Courneya, 2007 [27] | 2 | 1 | 0 | 1 | 4/6 |
Makari-Judson, 2007 [20] | 2 | 1 | 0 | 1 | 4/6 |
Heideman, 2009 [8] | 2 | 1 | 0 | 1 | 4/6 |
Biglia, 2010 | 1 | 1 | 0 | 0 | 2/6 |
Tredan, 2010 [44] | 1 | 1 | 0 | 1 | 3/6 |
Basaran, 2011 [45] | 1 | 0 | 0 | 1 | 2/6 |
Jeon, 2014 [46] | 1 | 1 | 1 | 1 | 4/6 |
Winkels, 2014 [47] | 2 | 1 | 1 | 1 | 5/6 |